Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Biosimilar vs Enbrel in Rheumatoid Arthritis
NCT04079374Phase 3Unknown
- Sponsor
- Farmak
- Start
- Sep 2018
- Primary completion
- Dec 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Farmak. Status: unknown.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04079374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079374.